STOCK TITAN

[Form 4] ALT5 Sigma Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4

Director David C. Danziger reported two stock transactions in ALT5 Sigma Corp (ALTS). On 07/02/2025 he was granted 10,000 shares of common stock at a reported price of $7.88, noted as a grant tied to his appointment to the board. Following that transaction his beneficial ownership was reported as 20,000 shares. A subsequent transaction on 08/14/2025 shows an additional 10,000 shares acquired at $7.30, keeping reported beneficial ownership at 20,000 shares. The Form 4 is signed and dated 10/09/2025, and the filer checked that the form was filed by one reporting person.

Il direttore David C. Danziger ha riportato due operazioni azionarie in ALT5 Sigma Corp (ALTS). Il 07/02/2025 gli è stato concesso 10,000 azioni ordinarie a un prezzo riportato di $7.88, indicato come una concessione legata al suo incarico nel consiglio. Dopo questa operazione la sua titolarità beneficiaria è stata riportata come 20,000 azioni. Un'operazione successiva il 08/14/2025 mostra ulteriori 10,000 azioni acquisite a $7.30, mantenendo la titolarità beneficiaria riportata a 20,000 azioni. Il Form 4 è firmato e datato 10/09/2025, e il dichiarante ha verificato che il modulo è stato presentato da una sola persona segnalante.

El director David C. Danziger reportó dos operaciones de acciones en ALT5 Sigma Corp (ALTS). En el 07/02/2025 se le otorgaron 10,000 acciones comunes a un precio reportado de $7.88, señalado como una concesión vinculada a su nombramiento en la junta. Después de esa operación su propiedad beneficiosa se reportó en 20,000 acciones. Una operación posterior el 08/14/2025 muestra un adicional de 10,000 acciones adquiridas a $7.30, manteniendo la propiedad beneficiosa reportada en 20,000 acciones. El Formulario 4 está firmado con fecha 10/09/2025, y el presentador verificó que el formulario fue presentado por una persona reportante.

다이렉터 David C. DanzigerALT5 Sigma Corp (ALTS)의 두 건의 주식 거래를 보고했습니다. 07/02/2025에 그는 10,000주를 보통주로 받았으며 보고된 가격은 $7.88로 표시되어 이사회에 임명된 것과 관련된 수여로 표시되었습니다. 이 거래 이후 그의 유익한 소유권은 20,000주로 보고되었습니다. 08/14/2025의 후속 거래에서는 추가로 10,000주가 $7.30에 취득되었고 보고된 유익한 소유권은 여전히 20,000주로 유지됩니다. Form 4는 10/09/2025에 서명 및 날짜가 기재되었으며, 신고자는 이 양식이 단일 보고인에 의해 제출되었음을 확인했습니다.

Le directeur David C. Danziger a rapporté deux transactions d’actions dans ALT5 Sigma Corp (ALTS). Le 07/02/2025, il a reçu 10 000 actions ordinaires à un prix déclaré de $7.88, indiqué comme une attribution liée à son appointment au conseil. Après cette transaction, sa propriété bénéficiaire a été déclarée comme 20 000 actions. Une transaction ultérieure le 08/14/2025 montre des 10 000 actions supplémentaires acquises à $7.30, maintenant la propriété bénéficiaire déclarée à 20 000 actions. Le formulaire 4 est signé et daté du 10/09/2025, et le déclarant a vérifié que le formulaire a été déposé par une seule personne déclaratrice.

Director David C. Danziger meldete zwei Aktiengeschäfte bei ALT5 Sigma Corp (ALTS). Am 07/02/2025 erhielt er 10,000 Stammaktien zu einem gemeldeten Preis von $7.88, angegeben als eine Zuwendung im Zusammenhang mit seiner Ernennung in das Vorstandsgremium. Nach dieser Transaktion wurde sein nutzbares Eigentum mit 20,000 Aktien gemeldet. Eine nachfolgende Transaktion am 08/14/2025 zeigt zusätzliche 10,000 Aktien, die zu $7.30 erworben wurden, wobei das gemeldete nutzbare Eigentum bei 20,000 Aktien bleibt. Das Formblatt 4 ist unterschrieben und datiert am 10/09/2025, und der Einreicher hat bestätigt, dass das Formular von einer meldenden Person eingereicht wurde.

المسؤول ديفيد س. دانزجر ذكر عمليتي معاملات أسهم في ALT5 Sigma Corp (ALTS). في 07/02/2025 مُنحت له 10,000 سهماً عادياً بسعر مُبلغ عنه $7.88، مشيرًا إليه باعتباره منحة مرتبطة بتعيينه في المجلس. بعد تلك المعاملة، أُبلغ عن ملكيته المستفيدة بمقدار 20,000 سهم. تُظهر معاملة لاحقة في 08/14/2025 إضافة 10,000 سهم مكتسب بسعر $7.30، مع الحفاظ على الملكية المستفيدة المبلغ عنها عند 20,000 سهم. النموذج 4 مُوقَّع ومؤرَّخ في 10/09/2025، وقد تحقق المُقدِّم أن النموذج قدم بواسطة شخص واحد مُبلَّغ عنه.

董事David C. DanzigerALT5 Sigma Corp (ALTS)记录了两笔股票交易。在07/02/2025,他获授<10,000股普通股,披露价格为$7.88,标注为与他被任命为董事会成员相关的授予。在这笔交易之后,他的受益所有权被报告为20,000股。随后在08/14/2025的交易中,又增添了10,000股,价格为$7.30,报告的受益所有权仍为20,000股。Form 4已签署并在10/09/2025贴上日期,且申报人确认该表格由一名申报人提交。

Positive
  • 10,000-share grant was issued upon board appointment on 07/02/2025
  • Additional 10,000-share acquisition on 08/14/2025 increased the director's direct stake
Negative
  • None.

Insights

New director received 10,000-share grant when appointed and later acquired 10,000 shares.

The disclosure shows a 10,000-share grant on 07/02/2025 tied to the reporting person's board appointment and a separate acquisition of 10,000 shares on 08/14/2025. Both transactions are reported as acquisitions and the filing lists total beneficial ownership as 20,000 shares after each event.

Governance implications are straightforward: the equity grant aligns the director's interests with shareholders and the later purchase increases direct stake. Monitor future Section 16 filings for any disposal codes or option grants that would change ownership or signal further compensation arrangements within the next 12 months.

Il direttore David C. Danziger ha riportato due operazioni azionarie in ALT5 Sigma Corp (ALTS). Il 07/02/2025 gli è stato concesso 10,000 azioni ordinarie a un prezzo riportato di $7.88, indicato come una concessione legata al suo incarico nel consiglio. Dopo questa operazione la sua titolarità beneficiaria è stata riportata come 20,000 azioni. Un'operazione successiva il 08/14/2025 mostra ulteriori 10,000 azioni acquisite a $7.30, mantenendo la titolarità beneficiaria riportata a 20,000 azioni. Il Form 4 è firmato e datato 10/09/2025, e il dichiarante ha verificato che il modulo è stato presentato da una sola persona segnalante.

El director David C. Danziger reportó dos operaciones de acciones en ALT5 Sigma Corp (ALTS). En el 07/02/2025 se le otorgaron 10,000 acciones comunes a un precio reportado de $7.88, señalado como una concesión vinculada a su nombramiento en la junta. Después de esa operación su propiedad beneficiosa se reportó en 20,000 acciones. Una operación posterior el 08/14/2025 muestra un adicional de 10,000 acciones adquiridas a $7.30, manteniendo la propiedad beneficiosa reportada en 20,000 acciones. El Formulario 4 está firmado con fecha 10/09/2025, y el presentador verificó que el formulario fue presentado por una persona reportante.

다이렉터 David C. DanzigerALT5 Sigma Corp (ALTS)의 두 건의 주식 거래를 보고했습니다. 07/02/2025에 그는 10,000주를 보통주로 받았으며 보고된 가격은 $7.88로 표시되어 이사회에 임명된 것과 관련된 수여로 표시되었습니다. 이 거래 이후 그의 유익한 소유권은 20,000주로 보고되었습니다. 08/14/2025의 후속 거래에서는 추가로 10,000주가 $7.30에 취득되었고 보고된 유익한 소유권은 여전히 20,000주로 유지됩니다. Form 4는 10/09/2025에 서명 및 날짜가 기재되었으며, 신고자는 이 양식이 단일 보고인에 의해 제출되었음을 확인했습니다.

Le directeur David C. Danziger a rapporté deux transactions d’actions dans ALT5 Sigma Corp (ALTS). Le 07/02/2025, il a reçu 10 000 actions ordinaires à un prix déclaré de $7.88, indiqué comme une attribution liée à son appointment au conseil. Après cette transaction, sa propriété bénéficiaire a été déclarée comme 20 000 actions. Une transaction ultérieure le 08/14/2025 montre des 10 000 actions supplémentaires acquises à $7.30, maintenant la propriété bénéficiaire déclarée à 20 000 actions. Le formulaire 4 est signé et daté du 10/09/2025, et le déclarant a vérifié que le formulaire a été déposé par une seule personne déclaratrice.

Director David C. Danziger meldete zwei Aktiengeschäfte bei ALT5 Sigma Corp (ALTS). Am 07/02/2025 erhielt er 10,000 Stammaktien zu einem gemeldeten Preis von $7.88, angegeben als eine Zuwendung im Zusammenhang mit seiner Ernennung in das Vorstandsgremium. Nach dieser Transaktion wurde sein nutzbares Eigentum mit 20,000 Aktien gemeldet. Eine nachfolgende Transaktion am 08/14/2025 zeigt zusätzliche 10,000 Aktien, die zu $7.30 erworben wurden, wobei das gemeldete nutzbare Eigentum bei 20,000 Aktien bleibt. Das Formblatt 4 ist unterschrieben und datiert am 10/09/2025, und der Einreicher hat bestätigt, dass das Formular von einer meldenden Person eingereicht wurde.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DANZIGER DAVID C.

(Last) (First) (Middle)
325 E. WARM SPRINGS RD.

(Street)
LAS VEGAS NV 89119

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ALT5 Sigma Corp [ ALTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 07/02/2025 07/02/2025 A 10,000 A $7.88 20,000 D
Common Stock 08/14/2025 08/14/2025 P 10,000 A $7.3 20,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Common stock granted on date Mr. Danziger was added as a board member.
Remarks:
/s/ David C. Danziger 10/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ALT5 Sigma Corp insider David C. Danziger report on Form 4 (ALTS)?

He reported a 10,000-share grant07/02/2025 at $7.88 and a separate 10,000-share acquisition on 08/14/2025 at $7.30, with beneficial ownership listed as 20,000 shares.

Why was the 10,000-share grant given to David C. Danziger?

The filing states the common stock was granted on the date Mr. Danziger was added as a board member.

What are the reported prices for the reported ALTS transactions?

The Form 4 lists prices of $7.88 for the 07/02/2025 grant and $7.30 for the 08/14/2025 acquisition.

When was the Form 4 signed by the reporting person?

The signature block shows the form was signed by David C. Danziger on 10/09/2025.

Does the Form 4 indicate joint filing or multiple reporting persons for ALTS?

No; the filer checked that the form was filed by one reporting person.
ALT5 Sigma Corporation

NASDAQ:ALTS

ALTS Rankings

ALTS Latest News

ALTS Latest SEC Filings

ALTS Stock Data

348.60M
95.99M
11.13%
14.98%
5.55%
Software - Application
Pharmaceutical Preparations
Link
United States
LAS VEGAS